Approval · Notice of Compliance 2065 · 1999
SAB-TIMOLOL: Notice of Compliance 2065
Issued October 7, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2065
- Date
- October 7, 1999
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Elevated intraocular pressure therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAB-TIMOLOL | 02166712 | Marketed |
| SAB-TIMOLOL | 02166720 | Marketed |
Medicinal ingredients
- TIMOLOL MALEATE 0.25 PER
- TIMOLOL MALEATE 0.5 PER